Cited by 51Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and ProtectionDrug Transport and Resistance Mechanisms

Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues

Open access
Robinson, Joshua F., Hamilton, Emily G., Lam, Juleen, Chen, Hao, Woodruff, Tracey J.·2020·Placenta

Abstract

Introduction Human cytochrome p450 (CYP) enzyme expression and activity is lower in the fetus as compared to the adult; however, limited quantitative data exists regarding the specific differences in magnitude or the degree of inducibility due to environmental factors. Methods We utilized a combination of in silico- and molecular-based approaches to profile and compare CYP expression/activity in human adult liver and fetal tissues. Using public datasets, we evaluated human CYP expression between: 1) placenta vs. adult livers; 2) fetal vs. adult livers; or 3) five compartments of the human placenta. We generated new experimental data, characterizing expression levels of nine CYPs in placenta/fetal liver vs. adult liver. In a subset of samples, we evaluated CYP3A4 activity. Finally, we summarized evidence of human fetal CYP expression/activity and environmental exposures during pregnancy. Results In silico, CYPs were predominately expressed at higher levels in the adult liver vs. fetal tissues, with a few noted exceptions. Sixty percent of CYP enzymes were expressed at nominal levels in the placenta. In wet-lab analyses, we observed significant CYP-specific differences in expression/activity between adult and fetal tissues; CYP2E1 and -3A4 were expressed significantly lower in fetal vs. adult livers, while CYP2J2 levels were similar. Discussion We provide a qualitative review of the expression of the CYP enzyme family in critical sites of xenobiotic distribution during human pregnancy and novel quantitative data regarding fetal CYP expression and activity during mid-gestation. Data outputs may be a resource for modeling predictions of chemical distribution and sensitivity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.placenta.2020.07.009

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver.

    “Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver (Hakkola et al., 1998; Robinson et al., 2020).”

    From Pregnancy-related maternal physiological adaptations and fetal chemical exposure (2023) · cites this paper as Robinson et al., 2020

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [1]Mitro SD, Johnson T, and Zota AR, Cumulative Chemical Exposures During Pregnancy and Early Development. Curr Environ Health Rep, 2015. 2(4): p. 367– 78. 26341623 PMC4626367
  2. [2]Sachdeva P, Patel BG, and Patel BK, Drug use in pregnancy; a point to ponder! Indian J Pharm Sci, 2009. 71(1): p. 1– 7. 20177448 PMC2810038
  3. [3]Morello-Frosch R,, Environmental Chemicals in an Urban Population of Pregnant Women and Their Newborns from San Francisco. Environ Sci Technol, 2016. 50(22): p. 12464– 12472. 27700069 PMC6681912
  4. [6]Lu G,, Physiologically-based pharmacokinetic (PBPK) models for assessing the kinetics of xenobiotics during pregnancy: achievements and shortcomings. Curr Drug Metab, 2012. 13(6): p. 695– 720. 22452453
  5. [7]Almazroo OA, Miah MK, and Venkataramanan R, Drug Metabolism in the Liver. Clin Liver Dis, 2017. 21(1): p. 1– 20. 27842765
  6. [8]Wang Y and Zhao S, in Vascular Biology of the Placenta 2010: San Rafael (CA). 21452443
  7. [10]Nelson DR, The cytochrome p450 homepage. Hum Genomics, 2009. 4(1): p. 59– 65. 19951895 PMC3500189
  8. [11]Rich KJ and Boobis AR, Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech, 1997. 39(5): p. 424– 35. 9408909
  9. [12]Myllynen P,, Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol, 2009. 5(12): p. 1483– 99. 19785513
  10. [13]Yan L,, Epigenomic Landscape of Human Fetal Brain, Heart, and Liver. J Biol Chem, 2016. 291(9): p. 4386– 98. 26719341 PMC4813467
  11. [14]Sadler NC,, Hepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human Development. Drug Metab Dispos, 2016. 44(7): p. 984– 91. 27084891 PMC4931891
  12. [15]Bonder MJ,, Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics, 2014. 15: p. 860. 25282492 PMC4287518
  13. [16]Wang YM,, Role of CAR and PXR in xenobiotic sensing and metabolism. Expert Opin Drug Metab Toxicol, 2012. 8(7): p. 803– 17. 22554043 PMC3593589
  14. [17]Saeed AI,, TM4 microarray software suite. Methods Enzymol, 2006. 411: p. 134– 93. 16939790
  15. [18]Robinson JF, Kapidzic M, Gormley M, Ona K, Dent T, Seifikar H, Hamilton EG, Fisher SJ, Transcriptional dynamics of cultured human villous cytotrophoblasts. Endocrinology, 2017. PMC5460928 28323933
  16. [19]Roadmap Epigenomics, C.,, Integrative analysis of 111 reference human epigenomes. Nature, 2015. 518(7539): p. 317– 30. 25693563 PMC4530010
  17. [20]Schmittgen TD and Livak KJ, Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 2008. 3(6): p. 1101– 8. 18546601
  18. [21]Rendic S, Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev, 2002. 34(1–2): p. 83– 448. 11996015
  19. [22]Hakura A,, An improvement of the Ames test using a modified human liver S9 preparation. J Pharmacol Toxicol Methods, 2001. 46(3): p. 169– 72. 12183193
  20. [23]Lagueux J,, Cytochrome P450 CYP1A1 enzyme activity and DNA adducts in placenta of women environmentally exposed to organochlorines. Environ Res, 1999. 80(4): p. 369– 82. 10330311
  21. [24]Huuskonen P,, The human placental proteome is affected by maternal smoking. Reprod Toxicol, 2016. 63: p. 22– 31. 27189315 PMC4991937
  22. [25]Santes-Palacios R,, Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention? Biomed Res Int, 2016. 2016: p. 5341081. PMC5220472 28105425
  23. [26]Shimizu Y,, Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A, 2000. 97(2): p. 779– 82. 10639156 PMC15407
  24. [27]Kleiner HE,, Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem Res Toxicol, 2002. 15(2): p. 226– 35. 11849049
  25. [28]Janssen BG,, Placental mitochondrial DNA and CYP1A1 gene methylation as molecular signatures for tobacco smoke exposure in pregnant women and the relevance for birth weight. J Transl Med, 2017. 15(1): p. 5. 28052772 PMC5209876
  26. [29]O’Shaughnessy PJ,, Maternal smoking and fetal sex significantly affect metabolic enzyme expression in the human fetal liver. J Clin Endocrinol Metab, 2011. 96(9): p. 2851– 60. 21715529
  27. [30]Lind L,, Genetic variation in the CYP1A1 gene is related to circulating PCB118 levels in a population-based sample. Environ Res, 2014. 133: p. 135– 40. 24926919 PMC5562272
  28. [31]Choudhary D,, Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch Biochem Biophys, 2005. 436(1): p. 50– 61. 15752708
  29. [32]Omiecinski CJ, Redlich CA, and Costa P, Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res, 1990. 50(14): p. 4315– 21. 1694720
  30. [33]Mo SL,, Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr Drug Metab, 2009. 10(7): p. 730– 53. 19702527
  31. [34]Erratico CA, Szeitz A, and Bandiera SM, Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6. Toxicol Sci, 2012. 129(2): p. 280– 92. 22738989
  32. [35]Erratico CA, Szeitz A, and Bandiera SM, Biotransformation of 2,2’,4,4’tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved. Chem Res Toxicol, 2013. 26(5): p. 721– 31. 23537005
  33. [36]Penell J,, Genetic variation in the CYP2B6 gene is related to circulating 2,2’,4,4’tetrabromodiphenyl ether (BDE-47) concentrations: an observational population-based study. Environ Health, 2014. 13(1): p. 34. 24885815 PMC4024654
  34. [37]Jones SM,, Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem Pharmacol, 1992. 43(8): p. 1876– 9. 1575782
  35. [38]Hakkola J,, Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol, 1996. 52(2): p. 379– 83. 8694864
  36. [39]Novak RF and Woodcroft KJ, The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res, 2000. 23(4): p. 267– 82. 10976571
  37. [40]Matsunaga T,, Expression and induction of CYP3As in human fetal hepatocytes. Biochem Biophys Res Commun, 2004. 318(2): p. 428– 34. 15120618
  38. [41]Maezawa K,, Cytochrome P450 3As gene expression and testosterone 6 betahydroxylase activity in human fetal membranes and placenta at full term. Biol Pharm Bull, 2010. 33(2): p. 249– 54. 20118548
  39. [42]Hakkola J,, Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate, 2001. 80(3): p. 193– 201. 11585982
  40. [43]Hill M,, Steroid profiling in pregnancy: a focus on the human fetus. J Steroid Biochem Mol Biol, 2014. 139: p. 201– 22. 23583279
  41. [44]Fukami M and Ogata T, Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects. Pediatr Int, 2014. 56(6): p. 805– 808. 25294558
  42. [45]Kragie L, Aromatase in primate pregnancy: a review. Endocr Res, 2002. 28(3): p. 121– 8. 12489562
  43. [46]Wolbold R,, Sex is a major determinant of CYP3A4 expression in human liver. Hepatology, 2003. 38(4): p. 978– 88. 14512885
  44. [47]Lamba V,, Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther, 2003. 307(3): p. 906– 22. 14551287
  45. [48]Yang L,, Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver. J Drug Metab Toxicol, 2012. 3(3): p. 1000119. PMC5699760 29177108
  46. [49]Kwekel JC,, Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics, 2010. 11: p. 675. 21118493 PMC3012673
  47. [50]Hart SN,, Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos, 2009. 37(1): p. 116– 21. 18845660 PMC2683655
  48. [51]Martignoni M, Groothuis GM, and de Kanter R, Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol, 2006. 2(6): p. 875– 94. 17125407

Cited by

Sorted by citations

Authors
Robinson, J. F., Hamilton, E. G., Lam, J., Chen, H., & Woodruff, T. J.
Affiliations
University of California, San Francisco (US)
Corresponding author
Robinson, Joshua F.
Venue
Placenta
Publisher
Elsevier BV
Published
2020-10
Volume
100
Pages
35-44
ISSN
0143-4004 (ISSN-L)
OpenAlex
W3047320223
Cited by
51
References
2
Citations by year
2026: 8 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 5
FWCI
5.78
Type
journal article
Language
en
Open access
Locations
  • Placenta (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Environmental Protection Agency (RD 83543301, RD 83467801)
  • California Environmental Protection Agency
  • National Institute of Environmental Health Sciences (P20ES018135, R21ES022422, R00ES023846, P01ES022841)
  • National Institute of Child Health and Human Development (T32HD007263)
  • National Institute of General Medical Sciences (R01GM118122)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
cytochrome P450, fetal liver, CYP3A4, CYP2E1, CYP2J2, enzyme expression, enzyme activity, pregnancy, environmental exposure, human liver, developmental differences
MeSH terms
Aromatase, Computer Simulation, Environmental Exposure, Female, Fetus, Humans, Liver, Placenta, Pregnancy, Pregnancy Trimester, Second, Cytochrome P-450 CYP3A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review